Please login to the form below

BRIC

This page shows the latest BRIC news and features for those working in and with pharma, biotech and healthcare.

Global pledge to immunise 300 million children

China's pledge means that all the emerging economies that make up BRICS – Brazil, Russia, India, China and South Africa - are making financial contributions towards childhood immunisation via GAVI.

Latest news

GSK raises stake in Indian subsidiary

Company eyes long-term growth of market
Indian pharma market set for 'significant' growth

Forecast to be worth $56bn by 2020, despite regulatory uncertainty
Building and delivering market access capabilities in emerging markets

Within these markets the BRIC countries (Brazil, Russia, India and China) are the dominant players. ... Positioning for growth in BRIC countries is an important strategy for pharma companies.
All eyes on pharma in Brazil

This article was originally published in the PME supplement Pharma and BRIC.
Brazil's healthcare conundrum

This article was orginially published in the PME supplement Pharma and BRIC.

More from news
Approximately 8 fully matching, plus 16 partially matching documents found.

Latest Intelligence

The focus of global healthcare communication

With the emergence of a multitude of on and offline communications channels and the rise in the strategic importance of new emerging national economies (BRICS), the outcome has been increased fragmentation
The AMR threat

For example, a lot of the increase in the BRIC countries is down to their continued development and ability to facilitate access to antibiotics for those that need them.
Choosing wisely

But the majority of emerging markets fall well short. According to World Bank data, each of the BRICS nations spent less than 5% of GDP on health in 2013, with China ... Despite this, some commentators question whether the biggest BRICS can still be
Seismic shifts: Hepatitis C and payers

So, will global pharma threaten to disinvest in Europe at a time when the BRIC countries are not delivering on their growth promise?
Russian innovation at the crossroads

Despite improvements, investors face rising risks

More from intelligence
Approximately 10 fully matching, plus 8 partially matching documents found.

Latest from PMHub

Deep Dive - MINT: opportunities in ‘frontier’ markets?

According to British economist Jim O’Neill, MINT is the new BRIC. ... These are the countries he believes are poised for strong economic growth, like the emerging markets of BRIC (Brazil, Russia, India and China) before them.
Men vs Women in emerging markets

Our latest interactive infographic compares male vs female health characteristics in the BRIC emerging marketS. ... Our latest interactive infographic compares the lives of men vs women in the BRIC emerging markets, and explores how societal factors
The challenges of conducting effective pharmaceutical market research in emerging markets

revenues. Some of the emerging markets, such as the BRIC nations of Brazil, Russia, India and China, are experiencing double-digit growth, as well as burgeoning public and private health care
Competition from within

Teva (Israel), CSL (Australia) and Aspen (South Africa) are notable exceptions, with the Indian generic giants Sun and Ranbaxy - which have since merged - the only representation from the ‘BRIC’ markets (Brazil,
Is MINT the next BRIC?

In 2001, British economist Jim O’Neill coined the now ubiquitous acronym ‘BRIC’, to stand for the four emerging economies of Brazil, Russia, India and China, which he suggested were all ... If we look back at the trends we have seen in the BRIC

More from PMHub
Approximately 2 fully matching, plus 12 partially matching documents found.

Featured jobs

Events Executive: DOE

Client Services Director- Flexible Working: Negotiable

Senior Medical Writer: Competitive salary plus benefits

Account Manager – Healthcare advertising: Salary TBC

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Account Director – UK Office: Excellent salary and benefits

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Report: Customer experience, shaping digital healthcare: In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D: The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it: What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...